Cell Death Mechanism Group, Institute for Ophthalmic Research, University of Tübingen, Germany; Centre for Integrative Neurosciences (CIN), University of Tübingen, Germany; Graduate Training Centre of Neuroscience (GTC), University of Tübingen, Germany.
Cell Death Mechanism Group, Institute for Ophthalmic Research, University of Tübingen, Germany; Graduate Training Centre of Neuroscience (GTC), University of Tübingen, Germany.
Prog Retin Eye Res. 2020 Jan;74:100772. doi: 10.1016/j.preteyeres.2019.07.005. Epub 2019 Jul 30.
The cellular mechanisms underlying hereditary photoreceptor degeneration are still poorly understood, a problem that is exacerbated by the enormous genetic heterogeneity of this disease group. However, the last decade has yielded a wealth of new knowledge on degenerative pathways and their diversity. Notably, a central role of cGMP-signalling has surfaced for photoreceptor cell death triggered by a subset of disease-causing mutations. In this review, we examine key aspects relevant for photoreceptor degeneration of hereditary origin. The topics covered include energy metabolism, epigenetics, protein quality control, as well as cGMP- and Ca-signalling, and how the related molecular and metabolic processes may trigger photoreceptor demise. We compare and integrate evidence on different cell death mechanisms that have been associated with photoreceptor degeneration, including apoptosis, necrosis, necroptosis, and PARthanatos. A special focus is then put on the mechanisms of cGMP-dependent cell death and how exceedingly high photoreceptor cGMP levels may cause activation of Ca-dependent calpain-type proteases, histone deacetylases and poly-ADP-ribose polymerase. An evaluation of the available literature reveals that a large group of patients suffering from hereditary photoreceptor degeneration carry mutations that are likely to trigger cGMP-dependent cell death, making this pathway a prime target for future therapy development. Finally, an outlook is given into technological and methodological developments that will with time likely contribute to a comprehensive overview over the entire metabolic complexity of photoreceptor cell death. Building on such developments, new imaging technology and novel biomarkers may be used to develop clinical test strategies, that fully consider the genetic heterogeneity of hereditary retinal degenerations, in order to facilitate clinical testing of novel treatment approaches.
遗传性光感受器变性的细胞机制仍知之甚少,而该病组的巨大遗传异质性使问题更加严重。然而,过去十年为退行性途径及其多样性提供了丰富的新知识。值得注意的是,一组致病突变引发的光感受器细胞死亡中,cGMP 信号转导起着核心作用。在这篇综述中,我们研究了遗传性光感受器变性的关键方面。涵盖的主题包括能量代谢、表观遗传学、蛋白质质量控制以及 cGMP 和 Ca 信号转导,以及相关的分子和代谢过程如何引发光感受器死亡。我们比较和整合了与光感受器变性相关的不同细胞死亡机制的证据,包括细胞凋亡、细胞坏死、坏死性凋亡和 PARthanatos。然后特别关注 cGMP 依赖性细胞死亡的机制,以及过高的光感受器 cGMP 水平如何激活 Ca 依赖性钙蛋白酶型蛋白酶、组蛋白去乙酰化酶和聚 ADP-核糖聚合酶。对现有文献的评估表明,一大群患有遗传性光感受器变性的患者携带的突变很可能引发 cGMP 依赖性细胞死亡,使该途径成为未来治疗开发的主要目标。最后,展望了技术和方法学的发展,这些发展将随着时间的推移有助于全面了解光感受器细胞死亡的整个代谢复杂性。在此基础上,新的成像技术和新型生物标志物可用于开发临床测试策略,充分考虑遗传性视网膜变性的遗传异质性,以便促进新型治疗方法的临床测试。